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INTRODUCTION 
 
The combination of high dose insulin and 
glucose has been repeatedly used in 
various cardiac conditions (chronic heart 
failure (1), acute myocardial infarction 
(AMI) (2), post-ischemic reperfusion (3), 
cardiac surgery (4)). It also has become 
part of the antidotal treatment of overdose 
with calcium channel and beta-adrenergic 
blocking agents (5).   
 
Insulin/glucose effects on distressed 
myocardium have been studied. 
Whereas hyperglycemia has shown 
increased mortality in patients with cardiac 
ischemia, some evidence suggests 
cardioprotective effects of insulin at the 
myocyte level given a strict normoglycemic 
metabolic state can be maintained (6). 
 
Little, however, is understood about the 
impact of insulin/glucose on healthy 
myocardium.  With this study we tried to 
assess the effects of insulin-euglycemia 
treatment on hemodynamics of healthy 
hearts in vivo. 
 
 
METHODS 
 
Ten (10) healthy, non-diabetic, females 
were enrolled in a prospective double blind 
cross-over trial.  Each volunteer received 
10 units regular insulin with 25 gm dextrose 
IV vs. placebo (0.9% saline IV).  After each 
infusion cardiac parameters (heart rate, 
blood pressure, fractional shortening of the 
left ventricle) were measured every 15 min 
for one hour.  ANOVA for repeated 
measures was calculated using 
insulin/glucose or placebo treatment as 
subject factors.  Post-hoc paired t-tests 
were done when ANOVA analysis 
suggested a significant effect at an alpha = 
0.05 level. 
 
Measurements for fractional shortening 
were obtained by cardiac ultrasound.  M 
mode images across the left ventricle (LV) 
in parasternal short axis probe position 
(see Image1) were recorded at the various 
time points.  Fractional shortening was 
found to represent the best approximation 
of LV function given the type of images 
obtained. 
In order to calculate the percentage of  
fractional shortening, end systolic diameter 
(ESD) and end diastolic diameter (EDD) 
were measured and computed in the 
following formula: 
( (EDD–ESD) / EDD ) x 100 
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RESULTS 
 
For heart rate (HR), systolic blood pressure 
(SBP), and fractional ventricular shortening 
(FVS) no significant differences in group 
means could be detected.   
There was a statistical significant difference 
towards lower diastolic blood pressures 
(DBP) in the insulin/glucose treatment arm 
(ANOVA p = 0.004).  Paired t-test analysis 
calculated significant differences for DBP 
between the treatment arms at 15, 30, and 
60 min (p = 0.02, 0.04, and 0.01 
respectively).  However, the treatment effect 
was measured as a decrease in DBP of only 
3.9-5.4 mmHg. 
 
 
DISCUSSION 
 
Best possible homogeneity of the study 
participants was achieved by selecting 
young, healthy, same sex individuals. Due 
to practical constraints, population size was 
kept small in this pilot study, which may 
impact the ability to detect a significant 
difference in means of the measured 
hemodynamic parameters. 
We used a low-dose insulin one time bolus 
regimen in this study. Our study participants 
received 0.13 IU/kg regular insulin bolus in 
average. Cardioprotective effects reported 
in the literature were observed with higher 
or different insulin regimens. The DIGAMI 
study insulin protocol used 5 IU/hr bolus 
initially with rate adjustments over time 
according to patients blood glucose levels. 
Recommended treatment doses used in 
calcium channel and beta-adrenergic 
blocking agent overdoses are 1 IU/kg insulin 
bolus followed by a 0.5 IU/kg/hr rate. 
Therefore, the lack of significant 
hemodynamic effects in this study might be 
in part contributed to the low dose insulin 
regimen used. 
Finally, significant effects of insulin on 
hemodynamics might just be subtle in 
healthy myocardium, whereas significant 
improvements of cardiac function occurs 
only in distressed or pathologic cardiac 
conditions. 
 
 
CONCLUSION 
 
In this study, low-dose insulin-euglycemia 
treatment seems to have little or no effect 
on the hemodynamic parameters of healthy, 
non-stressed hearts.  Therefore, 
cardioprotective effects from insulin/glucose 
might be more evident with use of high-dose 
insulin regimens or under conditions with 
maximal cardiac distress. 
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 Table 1:  Participant Characteristics 
Average Range 
Age (years) 27 20 - 37 
BMI (kg/m2) 27.17 20.8 - 34.8 
Baseline Blood 
Glucose Level (mg/dL) 94.8 81 - 127 
Figure 1 
Figure 2 
Figure 3 
Figure 4 
Figures 1 - 4: 
Changes in heart rate, systolic blood pressure, 
diastolic blood pressure, and % fractional 
shortening respectively over time in the two 
intervention arms. 
Data points represent population means, intervals 
represent standard errors around the population 
means for each set of measurements at the given 
time points. 
